352 related articles for article (PubMed ID: 20637871)
21. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
[TBL] [Abstract][Full Text] [Related]
22. Translating an Antagonist of Chemokine Receptor CXCR4: from bench to bedside.
Wong D; Korz W
Clin Cancer Res; 2008 Dec; 14(24):7975-80. PubMed ID: 19088012
[TBL] [Abstract][Full Text] [Related]
23. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.
Cho BS; Kim HJ; Konopleva M
Korean J Intern Med; 2017 Mar; 32(2):248-257. PubMed ID: 28219003
[TBL] [Abstract][Full Text] [Related]
24. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
[TBL] [Abstract][Full Text] [Related]
25. Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.
Peled A; Hardan I; Trakhtenbrot L; Gur E; Magid M; Darash-Yahana M; Cohen N; Grabovsky V; Franitza S; Kollet O; Lider O; Alon R; Rechavi G; Lapidot T
Stem Cells; 2002; 20(3):259-66. PubMed ID: 12004084
[TBL] [Abstract][Full Text] [Related]
26. [Advance of research on SDF-1/CXCR4 axis and angiogenesis in leukemia--review].
Bao CH; He QT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):447-51. PubMed ID: 18426684
[TBL] [Abstract][Full Text] [Related]
27. Targeting the microenvironment in acute myeloid leukemia.
Rashidi A; Uy GL
Curr Hematol Malig Rep; 2015 Jun; 10(2):126-31. PubMed ID: 25921388
[TBL] [Abstract][Full Text] [Related]
28. Chemokines in hematopoiesis.
Broxmeyer HE
Curr Opin Hematol; 2008 Jan; 15(1):49-58. PubMed ID: 18043246
[TBL] [Abstract][Full Text] [Related]
29. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Wang J; Loberg R; Taichman RS
Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
[TBL] [Abstract][Full Text] [Related]
30. [Effects of anti-CXCR4 monoclonal antibody on adhesion and proliferation of human acute myelocytic leukemia cell line HL-60].
Wei L; Kong PY; Chen XH; Peng XG; Zeng DF; Chang C; Yang WB; Liu H; Liu L; Wang QY; Zhang Y
Ai Zheng; 2004 Nov; 23(11):1273-7. PubMed ID: 15522172
[TBL] [Abstract][Full Text] [Related]
31. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
[TBL] [Abstract][Full Text] [Related]
32. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
Petit I; Szyper-Kravitz M; Nagler A; Lahav M; Peled A; Habler L; Ponomaryov T; Taichman RS; Arenzana-Seisdedos F; Fujii N; Sandbank J; Zipori D; Lapidot T
Nat Immunol; 2002 Jul; 3(7):687-94. PubMed ID: 12068293
[TBL] [Abstract][Full Text] [Related]
33. CXCR4 and cancer.
Furusato B; Mohamed A; Uhlén M; Rhim JS
Pathol Int; 2010 Jul; 60(7):497-505. PubMed ID: 20594270
[TBL] [Abstract][Full Text] [Related]
34. Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.
Scala S
Clin Cancer Res; 2015 Oct; 21(19):4278-85. PubMed ID: 26199389
[TBL] [Abstract][Full Text] [Related]
35. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
Juarez J; Dela Pena A; Baraz R; Hewson J; Khoo M; Cisterne A; Fricker S; Fujii N; Bradstock KF; Bendall LJ
Leukemia; 2007 Jun; 21(6):1249-57. PubMed ID: 17410186
[TBL] [Abstract][Full Text] [Related]
36. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
37. SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma.
Faber A; Goessler UR; Hoermann K; Schultz JD; Umbreit C; Stern-Straeter J
Oncol Rep; 2013 Jun; 29(6):2325-31. PubMed ID: 23563306
[TBL] [Abstract][Full Text] [Related]
38. SDF-1 and CXCR4 in normal and malignant hematopoiesis.
Juarez J; Bendall L
Histol Histopathol; 2004 Jan; 19(1):299-309. PubMed ID: 14702198
[TBL] [Abstract][Full Text] [Related]
39. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer].
Ding YL; Fu QY; Tang SF; Zhang JL; Li ZY; Li ZT
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):210-3. PubMed ID: 19563077
[TBL] [Abstract][Full Text] [Related]
40. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.
Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T
Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
